Here’s why Raffles Medical share price (SGX: BSL) plunged 12%
LIFETIME MEMBERSHIP My last coverage on Raffles Medical share price (SGX: BSL) was in June 2020. Back then, the counter was recovering from the initial impact of the pandemic. Nonetheless, Raffles Medical share price (SGX: BSL) remained sluggish for most of 2020 until news of vaccines broke out in November 2020. Since then, global roll-out of vaccine programmes and easing of border restrictions led to Raffles Medical share price (SGX: BSL) rocketing to a near-record high of $1.55 in October 2021.
Unexpectedly, the bullish form Raffles Medical share price (SGX: BSL) was brought to a screeching halt when the shares plunged 12% to reach a low of $1.35 on 3 November 2021. To be honest, the volatility of Raffles Medical share price (SGX: BSL) is rather rare and it prompted a Lifetime Member of SG Wealth Builder to seek an insight from me.
There are analysts who claimed that the recent correction of Raffles Medical share price (SGX: BSL) is due to the revised on-arrival COVID PCR test requirements for travellers arriving in or transiting through Singapore (from 7 Oct 2021 onwards, travellers from CAT II, III & IV countries do not need to do on-arrival PCR tests). For perspective, Raffles Medical conducted over 600,000 COVID-9 tests and screened more than six million travellers in 2020.
Read More